The Mycophenolic Acid Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including the rising prevalence of autoimmune diseases, increasing organ transplant procedures, and a growing awareness of the therapeutic benefits of mycophenolic acid. The demand for...